These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 18103536)

  • 1. [Observations on the effect of parpanit on motility disorders from extrapyramidal and pyramidal lesions].
    DAVINI V; BORELLINI A
    Minerva Med; 1948 Oct; 39(43 Pt 2):432-5. PubMed ID: 18103536
    [No Abstract]   [Full Text] [Related]  

  • 2. [A new therapy for extra-pyramidal motor disorders: "Parpanit"].
    MONAKOW KH
    Med Hyg (Geneve); 1947 Jan; 5(89):7. PubMed ID: 20342183
    [No Abstract]   [Full Text] [Related]  

  • 3. Artane in the treatment of Parkinson's disease; a report of its effectiveness alone and in combination with benadryl and parpanit.
    SCHWAB RS; TILLMANN WR
    N Engl J Med; 1949 Sep; 241(13):483-5. PubMed ID: 18140791
    [No Abstract]   [Full Text] [Related]  

  • 4. [Parpanit in the treatment of intentional tremor; multiple sclerosis and upper red kernel syndrome].
    BICKEL G; DUBOIS JP
    Rev Med Suisse Romande; 1947 Oct; 67(10):708-16. PubMed ID: 18857554
    [No Abstract]   [Full Text] [Related]  

  • 5. [The treatment of Parkinson's syndrome with parpanite].
    BOOIJ J
    Ned Tijdschr Geneeskd; 1948 Apr; 92(14):994-1000. PubMed ID: 18872076
    [No Abstract]   [Full Text] [Related]  

  • 6. [About Parpanit, a new substance that influences extrapyramidal movement disorders].
    GRUNTHAL E
    Praxis; 1947 Jan; 36(3):46. PubMed ID: 20342364
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical experience in treating extrapyramidal disorders with a new agent, parpanit].
    HARTMANN K
    Praxis; 1947 Jan; 36(3):46. PubMed ID: 20342365
    [No Abstract]   [Full Text] [Related]  

  • 8. [Parpanit in therapy of extrapyramidal diseases].
    GOKAY FK; TUKEL K
    Schweiz Med Wochenschr; 1951 Jun; 81(24):582-3. PubMed ID: 14866039
    [No Abstract]   [Full Text] [Related]  

  • 9. [Morbus Little treated with parpanite].
    JERSILD T
    Ugeskr Laeger; 1949 Apr; 111(16):449-51. PubMed ID: 18151545
    [No Abstract]   [Full Text] [Related]  

  • 10. [Parpanit and artane as pediatric antispasmodics].
    MELIN KA; HERRLIN KM
    Nord Med; 1952 Mar; 47(10):312-4. PubMed ID: 14911006
    [No Abstract]   [Full Text] [Related]  

  • 11. [Parpanit therapy of extrapyramidal disorders].
    BEHREND RC
    Munch Med Wochenschr; 1951 Jan; 93(1):35-8. PubMed ID: 14815624
    [No Abstract]   [Full Text] [Related]  

  • 12. [About the preparation parpanite; used for 30 patients with Parkinsonism].
    MUNCH-PETERSEN S
    Ugeskr Laeger; 1949 Apr; 111(16):443-5. PubMed ID: 18151542
    [No Abstract]   [Full Text] [Related]  

  • 13. [Parpanite treatment of paralysis agitans].
    DALSGAARD-NIELSEN T
    Ugeskr Laeger; 1949 Apr; 111(16):446. PubMed ID: 18151543
    [No Abstract]   [Full Text] [Related]  

  • 14. [About parpanite; treatment results spec. by encephalitic parkinsonism].
    HERMANN K
    Ugeskr Laeger; 1949 Apr; 111(16):447-9. PubMed ID: 18151544
    [No Abstract]   [Full Text] [Related]  

  • 15. The quantitative evaluation of spasmolytic drugs in vitro.
    MILLER LC; BECKER TJ; TAINTER ML
    J Pharmacol Exp Ther; 1948 Mar; 92(3):260-8. PubMed ID: 18907212
    [No Abstract]   [Full Text] [Related]  

  • 16. [Experience with the new preparation Parpanit in the treatment of diseases of the extrapyramidal motor system].
    HABERMANN H
    Nervenarzt; 1948 May; 19(5):233-8. PubMed ID: 18881951
    [No Abstract]   [Full Text] [Related]  

  • 17. Further clinical observations on the use of dibutoline, a new antispasmodic drug.
    MARQUARDT GH; CASE JT
    Am J Med Sci; 1948 Aug; 216(2):203-11. PubMed ID: 18884740
    [No Abstract]   [Full Text] [Related]  

  • 18. Spasmolytic activity of synthetic drugs.
    RANDALL LO
    J Am Pharm Assoc Am Pharm Assoc (Baltim); 1948 Sep; 9(9):536-9. PubMed ID: 18882128
    [No Abstract]   [Full Text] [Related]  

  • 19. [On the spasmolytic and parasympatholytic properties of 2-diethylaminoethyl substituted phenylglycolates].
    BUCHEL L; LEVY J; PERNOT R
    C R Seances Soc Biol Fil; 1948 Jan; 142(1-2):58-60. PubMed ID: 18859940
    [No Abstract]   [Full Text] [Related]  

  • 20. The cholinesterase-inhibitory characteristics of Parpanit and its analogues in relation to their protective effectiveness in the treatment of sarin-poisoned rodents.
    Bannard RA; Helie JG; Price JE; Coleman IW
    Can J Physiol Pharmacol; 1969 Dec; 47(12):1036-8. PubMed ID: 5360361
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.